• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫肌瘤切除术后非典型溶血性尿毒症综合征:一例报告。

Atypical hemolytic uremic syndrome after myomectomy: A case report.

作者信息

Musselman Kelsey, Laurence Jeffrey, Magro Cynthia, Rahbari Pasha, Di Vitantonio Thomas, Havryliuk Yelena

机构信息

Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, United States of America.

Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, United States of America.

出版信息

Case Rep Womens Health. 2022 Jun 11;35:e00424. doi: 10.1016/j.crwh.2022.e00424. eCollection 2022 Jul.

DOI:10.1016/j.crwh.2022.e00424
PMID:35769946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9234065/
Abstract

Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy due to inability to regulate the complement cascade, resulting in thrombocytopenia, intravascular hemolysis, and end-organ damage. Over 70% of cases are associated with mutations in complement or complement regulatory proteins, and some two-thirds have recognized complement-activating conditions triggering an aHUS event. We describe a case of aHUS after abdominal myomectomy in a 42-year-old woman that was managed with plasma exchange and eculizumab (an anti-C5 monoclonal antibody). The diagnosis was confirmed by biopsy of normal-appearing deltoid skin that demonstrated microvascular C5b-9 deposition, diagnostic of systemic complement pathway activation. Although extremely uncommon following gynecologic surgery, aHUS should be considered in the setting of postoperative oliguric acute kidney injury, as prompt diagnosis is necessary to prevent significant morbidity and mortality.

摘要

非典型溶血性尿毒症综合征(aHUS)是一种罕见的血栓性微血管病,由于无法调节补体级联反应,导致血小板减少、血管内溶血和终末器官损伤。超过70%的病例与补体或补体调节蛋白的突变有关,约三分之二的病例有已知的补体激活情况引发aHUS事件。我们描述了一例42岁女性子宫肌瘤切除术后发生aHUS的病例,该病例采用血浆置换和依库珠单抗(一种抗C5单克隆抗体)进行治疗。通过外观正常的三角肌皮肤活检证实了诊断,活检显示微血管C5b-9沉积,可诊断为系统性补体途径激活。尽管在妇科手术后极为罕见,但在术后少尿性急性肾损伤的情况下应考虑aHUS,因为及时诊断对于预防严重的发病率和死亡率至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3606/9234065/6f095bf118bb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3606/9234065/045f91fbea95/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3606/9234065/39b6a0bf2b3f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3606/9234065/68fc70782a03/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3606/9234065/6f095bf118bb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3606/9234065/045f91fbea95/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3606/9234065/39b6a0bf2b3f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3606/9234065/68fc70782a03/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3606/9234065/6f095bf118bb/gr4.jpg

相似文献

1
Atypical hemolytic uremic syndrome after myomectomy: A case report.子宫肌瘤切除术后非典型溶血性尿毒症综合征:一例报告。
Case Rep Womens Health. 2022 Jun 11;35:e00424. doi: 10.1016/j.crwh.2022.e00424. eCollection 2022 Jul.
2
Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.非典型溶血尿毒综合征患者孤立性小肠血栓性微血管病 - 病例报告。
BMC Nephrol. 2020 Mar 24;21(1):104. doi: 10.1186/s12882-020-01766-0.
3
An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.在体外对补体激活进行测试,为溶血尿毒综合征的依库珠单抗个体化治疗提供依据。
Am J Kidney Dis. 2019 Jul;74(1):56-72. doi: 10.1053/j.ajkd.2018.11.012. Epub 2019 Mar 7.
4
Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.病例报告:非典型溶血尿毒综合征中的新型 FHR2 变异体:肾移植中转化医学方法的案例研究。
Front Immunol. 2022 Nov 14;13:1008294. doi: 10.3389/fimmu.2022.1008294. eCollection 2022.
5
Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.妊娠早期非典型溶血性尿毒症综合征经依库珠单抗成功治疗。
Exp Hematol Oncol. 2017 Jan 13;6:4. doi: 10.1186/s40164-017-0064-7. eCollection 2017.
6
Atypical hemolytic uremic syndrome: a case report.非典型溶血性尿毒症综合征:一例报告。
J Med Case Rep. 2020 Jan 13;14(1):11. doi: 10.1186/s13256-019-2334-y.
7
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome.血栓性微血管病的临床评估:疑似非典型溶血尿毒症综合征患者的识别
Thromb J. 2016 Oct 4;14(Suppl 1):19. doi: 10.1186/s12959-016-0114-0. eCollection 2016.
8
Effect of eculizumab and recombinant human soluble thrombomodulin combination therapy in a 7-year-old girl with atypical hemolytic uremic syndrome due to anti-factor H autoantibodies.依库珠单抗与重组人可溶性血栓调节蛋白联合治疗对一名因抗H因子自身抗体导致非典型溶血尿毒综合征的7岁女童的疗效。
CEN Case Rep. 2014 May;3(1):110-117. doi: 10.1007/s13730-013-0097-7. Epub 2013 Sep 12.
9
Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.在影响原肾的成人非典型溶血性尿毒症综合征患者的临床实践中使用依库珠单抗的见解:19 例分析。
Am J Kidney Dis. 2014 Jan;63(1):40-8. doi: 10.1053/j.ajkd.2013.07.011. Epub 2013 Sep 8.
10
Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.非典型溶血性尿毒症综合征:病例报告的荟萃分析证实基因突变的患病率及治疗方案的转变
Ther Apher Dial. 2018 Apr;22(2):178-188. doi: 10.1111/1744-9987.12641. Epub 2017 Dec 17.

引用本文的文献

1
A Rare Case of Atypical Haemolytic Syndrome Following Right Retrograde Intrarenal Surgery (RIRS).右逆行性肾内手术(RIRS)后发生非典型溶血性综合征的罕见病例。
Cureus. 2025 Jun 23;17(6):e86585. doi: 10.7759/cureus.86585. eCollection 2025 Jun.
2
Transvaginal natural orifice endoscopic surgery for myomectomy: Can it be a conventional surgery?经阴道自然腔道内镜下子宫肌瘤切除术:它能成为一种常规手术吗?
Front Surg. 2022 Nov 4;9:1013918. doi: 10.3389/fsurg.2022.1013918. eCollection 2022.

本文引用的文献

1
Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults.长效补体C5抑制剂ravulizumab治疗成人非典型溶血性尿毒症综合征的长期疗效和安全性
Kidney Int Rep. 2021 Mar 24;6(6):1603-1613. doi: 10.1016/j.ekir.2021.03.884. eCollection 2021 Jun.
2
Defining treatment duration in atypical hemolytic uremic syndrome in adults: a clinical and pathological approach.成人非典型溶血性尿毒综合征的治疗持续时间界定:临床与病理学方法。
Clin Adv Hematol Oncol. 2020 Apr;18(4):221-230.
3
Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding.
依库珠单抗用于治疗继发于手术侵袭性应激和出血的严重血栓性微血管病。
Intern Med. 2020;59(1):93-99. doi: 10.2169/internalmedicine.3315-19. Epub 2020 Jan 1.
4
Pathogenesis of Atypical Hemolytic Uremic Syndrome.非典型溶血尿毒综合征的发病机制。
J Atheroscler Thromb. 2019 Feb 1;26(2):99-110. doi: 10.5551/jat.RV17026. Epub 2018 Nov 2.
5
Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.非典型溶血尿毒综合征:病理生理学、诊断及治疗的最新进展
Ther Apher Dial. 2019 Feb;23(1):4-21. doi: 10.1111/1744-9987.12763. Epub 2018 Oct 29.
6
Haemolytic uraemic syndrome.溶血尿毒综合征。
Lancet. 2017 Aug 12;390(10095):681-696. doi: 10.1016/S0140-6736(17)30062-4. Epub 2017 Feb 25.
7
Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.非典型溶血性尿毒症综合征(aHUS):准确诊断的关键要点
Clin Adv Hematol Oncol. 2016 Nov;14 Suppl 11(11):2-15.
8
Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.补体激活相关疾病背景下的非典型溶血性尿毒症综合征:病例报告及依库珠单抗治疗证据综述
J Nephrol. 2017 Jun;30(3):347-362. doi: 10.1007/s40620-016-0357-7. Epub 2016 Nov 15.
9
Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with Eculizumab.依库珠单抗成功治疗术后非典型溶血性尿毒症综合征
Intern Med. 2016;55(9):1171-5. doi: 10.2169/internalmedicine.55.5955. Epub 2016 May 1.
10
Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome.皮肤活检在非典型溶血尿毒综合征诊断中的作用
Am J Dermatopathol. 2015 May;37(5):349-56; quiz 357-9. doi: 10.1097/DAD.0000000000000234.